-+ 0.00%
-+ 0.00%
-+ 0.00%

ACRIVON THERAPEUTICS INC - ACR-2316 PHASE 1 SHOWS FAVORABLE TOLERABILITY

路透·01/08/2026 12:30:00

登录查看新闻详情